Picard Medical, Inc.

About Picard Medical, Inc.

Picard Medical, Inc. is the parent company of SynCardia Systems, LLC, a global leader in total artificial heart technology. The company focuses on developing, manufacturing, and commercializing the SynCardia Total Artificial Heart (STAH), aiming to innovate in cardiac care and improve patient quality of life.

Products & Services

SynCardia Total Artificial Heart (STAH):The only commercially available total artificial heart approved by the FDA and Health Canada, available in 70 cc and 50 cc sizes, supported by hospital-based and portable home driver systems to aid mobility while awaiting a donor heart.

Emperor System:A fully implantable total artificial heart system under development, designed to eliminate external drivers and set a new standard in therapy.

Specialties

Total Artificial Heart Technology Cardiac Care Innovation

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: IPO T: - FT: IPO	A: 17000000 MR: - FA: $17 million FAN: 17000000	D: 2025-09-02 FD: 2025-09-02	4 investors

IPO Latest

2025-09-02

$17.0M

4 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

J

Jack Copeland

Doctor

R

Richard Smith

M

Marvin Slepian

E

Eric Ribner

B

Brittany Lanza

Media Contact

View 2 more team members with Pro

Unlock Full Team Directory

Recent News